https://hgs.cx/wp-content/uploads/2021/05/iStock-1181024482.webp 457 700 Kimberly Dou https://hgs.cx/wp-content/uploads/2021/02/HGS-logo.svg Kimberly Dou2021-05-04 14:29:002021-07-30 08:15:50Effectively handling clinical denials amid a pandemic backlog of elective surgeries
https://hgs.cx/wp-content/uploads/2021/01/Hero_Industry_Healthcare.webp 782 1439 Virgil Wong https://hgs.cx/wp-content/uploads/2021/02/HGS-logo.svg Virgil Wong2021-02-01 17:06:512021-07-30 08:31:46Preventing and appealing clinical denials with analytics, automation, and AI
U.S. hospitals lose $262 billion due to denied claims each year, representing 10% of the total claims paid. Unraveling the root cause of denials costs an average of $118 for each claim. Applying modern technology — such as analytics, automation, and artificial intelligence (AI) — can help to increase the number of clinical denials investigated, boost appeal effectiveness, and unearth root cause.